相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical Model of Breast Cancer Bone Metastases
Christian Schem et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Distinctive expression pattern of cystathionine--synthase and cystathionine--lyase identifies mesenchymal stromal cells transition to mineralizing osteoblasts
Laura Gambari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Using hydrogen sulfide to design and develop drugs
Vincenzo Calderone et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Hydrogen Sulfide Is a Novel Regulator of Bone Formation Implicated in the Bone Loss Induced by Estrogen Deficiency
Francesco Grassi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Targeted delivery to bone and mineral deposits using bisphosphonate ligands
Lisa E. Cole et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
A Crisis in the Treatment of Osteoporosis
Sundeep Khosla et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Postmenopausal Osteoporosis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter
John L. Wallace et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Hydrogen Sulfide Maintains Mesenchymal Stem Cell Function and Bone Homeostasis via Regulation of Ca2+ Channel Sulfhydration
Yi Liu et al.
CELL STEM CELL (2014)
Alendronate-induced atypical bone fracture: evidence that the drug inhibits osteogenesis
S. Patntirapong et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Hydrogen Sulfide Releasing Capacity of Natural Isothiocyanates: Is It a Reliable Explanation for the Multiple Biological Effects of Brassicaceae?
Valentina Citi et al.
PLANTA MEDICA (2014)
Sodium hydrosulfide inhibits the differentiation of osteoclast progenitor cells via NRF2-dependent mechanism
Laura Gambari et al.
PHARMACOLOGICAL RESEARCH (2014)
Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates
Mohammad Kharazmi et al.
RHEUMATOLOGY (2014)
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player?
Alma Martelli et al.
VASCULAR PHARMACOLOGY (2014)
Arylthioamides as H2S Donors: L-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo
Alma Martelli et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Incidence of Atypical Nontraumatic Diaphyseal Fractures of the Femur
Richard M. Dell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Hydrogen sulphide: novel opportunity for drug discovery
Alma Martelli et al.
MEDICINAL RESEARCH REVIEWS (2012)
The relationship between the chemistry and biological activity of the bisphosphonates
Frank H. Ebetino et al.
BONE (2011)
Biochemical and molecular mechanisms of action of bisphosphonates
Michael J. Rogers et al.
BONE (2011)
A One-Pot Synthesis of 1-Hydroxy-1,1-bis(phosphonic acid)s Starting from the Corresponding Carboxylic Acids
Maxim Egorov et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2011)
T Cell Suppression by Osteoclasts In Vitro
Francesco Grassi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism
Michael J. Rogers et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaw-2009 Update
Salvatore L. Ruggiero et al.
AUSTRALIAN ENDODONTIC JOURNAL (2009)
Inhibition of Osteoblast Function In Vitro by Aminobisphosphonates
Isabel R. Orriss et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells
Fraser P. Coxon et al.
BONE (2008)
Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro
Aymen I. Idris et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Lowering Bone Mineral Affinity of Bisphosphonates as a Therapeutic Strategy to Optimize Skeletal Tumor Growth Inhibition In vivo
Pierrick G. J. Fournier et al.
CANCER RESEARCH (2008)
Hydrogen sulfide mediates the vasoactivity of garlic
Gloria A. Benavides et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells
Gustavo Duque et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
O. Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate
Matthew R. Allen et al.
BONE (2006)
Severely suppressed bone turnover: A potential complication of alendronate therapy
CV Odvina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Ten years' experience with alendronate for osteoporosis in postmenopausal women
HG Bone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
GY Boivin et al.
BONE (2000)
分享论文
